Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of corticotropin-releasing hormone on duodenal markers and gastric sensorimotor function in healthy volunteers
2021-000594-81Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of corticorelin ovine triflutate, sponsored by UZ Leuven. Primary endpoints: Effect of corticotropin-releasing hormone on duodenal mast cell count, Effect on duodenal eosinophil count and 4 more. Started Mar 2021; status: completed.
02
Drugs
corticorelin ovine triflutate
Beyond the preview
Go deeper on 2021-000594-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000594-81.